keyword
MENU ▼
Read by QxMD icon Read
search

Carvedilol esrd

keyword
https://www.readbyqxmd.com/read/29366423/therapeutic-approach-to-patients-with-heart-failure-with-reduced-ejection-fraction-and-end-stage-renal-disease
#1
REVIEW
Chakradhari Inampudi, Paulino Alvarez, Rabea Asleh, Alexandros Briasoulis
BACKGROUND: Several risk factors including Ischemic heart disease, uncontrolled hypertension, high output Heart Failure (HF) from shunting through vascular hemodialysis access, and anemia, contribute to development of HF in patients with End-Stage Renal Disease (ESRD). Guidelinedirected medical and device therapy for Heart Failure with Reduced Ejection Fraction (HFrEF) has not been extensively studied and may have limited safety and efficacy in patients with ESRD. RESULTS: Maintenance of interdialytic and intradialytic euvolemia is a key component of HF management in these patients but often difficult to achieve...
March 14, 2018: Current Cardiology Reviews
https://www.readbyqxmd.com/read/24991534/carvedilol-ameliorates-early-diabetic-nephropathy-in-streptozotocin-induced-diabetic-rats
#2
Mohamed A Morsy, Salwa A Ibrahim, Entesar F Amin, Maha Y Kamel, Soha A Abdelwahab, Magdy K Hassan
Diabetic nephropathy results in end-stage renal disease. On the other hand, carvedilol has been reported to have various pharmacological properties. The aim of this study therefore is to evaluate the possible protective effect of carvedilol on streptozotocin-induced early diabetic nephropathy and various mechanisms underlie this effect in rats. Single i.p. injection of streptozotocin (65 mg/kg) was administered to induce early diabetic nephropathy in Wistar rats. Oral administration of carvedilol at a dose level of 1 and 10 mg/kg daily for 4 weeks resulted in nephroprotective effect as evident by significant decrease in serum creatinine level, urinary albumin/creatinine ratio, and kidney index as well as renal levels of malondialdehyde, nitric oxide, tumor necrosis factor- α , and cyclooxygenase-2 with a concurrent increase in creatinine clearance and renal reduced glutathione level compared to diabetic untreated rats...
2014: BioMed Research International
https://www.readbyqxmd.com/read/23045427/medical-options-to-fight-mortality-in-end-stage-renal-disease-a-review-of-the-literature
#3
REVIEW
Rafael Kramann, Jürgen Floege, Markus Ketteler, Nikolaus Marx, Vincent M Brandenburg
Many therapeutic strategies for end-stage renal disease (ESRD) patients have failed to exhibit survival improvement in large-scale randomized controlled trials (RCTs). The current review gives an overview on the medical strategies for treatment of ESRD patients that have previously been tested in RCTs with mortality reduction as pre-specified study endpoint. We identified 19 RCTs with the following therapeutic strategies: haematocrit increase by erythropoietin (n = 1), growth hormone application (n = 1), lipid-lowering by statins (n = 3), renin-angiotensin system blockage (n = 4), β-receptor blockage (n = 1), homocysteine lowering (n = 5), application of anti-oxidative substances (n = 2), omega-3-fatty-acid supplementation (n = 1) and calcium-free phosphate binders (n = 1)...
December 2012: Nephrology, Dialysis, Transplantation
https://www.readbyqxmd.com/read/20187715/comparative-effects-of-carvedilol-and-lercanidipine-on-ultrafiltration-and-solute-transport-in-capd-patients
#4
COMPARATIVE STUDY
Cevat Topal, Reha Erkoc, Hayriye Sayarlioglu, Ekrem Dogan, Huseyin Beyenik
BACKGROUND: Peritonitis, the type of buffer used in the dialysate, continue ambulatory peritoneal dialysis (CAPD) of greater than two years duration, increased exposure to dialysate glucose, diabetes mellitus, and the use of beta blockers may contribute to impaired ultrafiltration. OBJECTIVES: The aim of the present study is to compare the effects of a calcium-channel blocker and a beta-blocker on the peritoneal transport and clearance. METHODS: We studied 48 patients with ESRD on chronic peritoneal dialysis, included 27 females and 19 males with mean age 42...
2009: Renal Failure
https://www.readbyqxmd.com/read/18090678/cardiovascular-disease-in-dialysis-patients-do-some-antihypertensive-drugs-have-specific-antioxidant-effects-or-is-it-just-blood-pressure-reduction-does-antioxidant-treatment-reduce-the-risk-for-cardiovascular-disease
#5
REVIEW
Shakil Aslam
PURPOSE OF REVIEW: Patients with end-stage renal disease have an extremely high cardiovascular disease mortality. Oxidative stress is one of the 'nontraditional' risk factors for cardiovascular disease mortality in dialysis patients. This review discusses antioxidant activity of the commonly prescribed antihypertensive agents and the effects of antioxidant interventions on cardiovascular disease mortality in patients with end-stage renal disease. RECENT FINDINGS: Several lines of evidence confirm antioxidant activity of the renin-angiotensin-aldosterone antagonists, some of the calcium channel blockers, carvedilol, and hydralazine...
January 2008: Current Opinion in Nephrology and Hypertension
https://www.readbyqxmd.com/read/15302018/clinical-trials-update-from-the-european-society-of-cardiology-heart-failure-meeting-shape-bring-up-2-vas-cola-ii-fosidial-betacar-casino-and-meta-analysis-of-cardiac-resynchronisation-therapy
#6
Alison P Coletta, John G F Cleland, Nick Freemantle, Andrew L Clark
This article continues a series of reports on recent research developments in the field of heart failure. Key presentations made at the European Society of Cardiology Heart Failure Update meeting, held in Wroclaw, Poland, in June 2004 are reported. The SHAPE study identified a need to educate general practitioners (GPs) in order to optimise treatment of heart failure in primary care. BRING-UP 2 VAS showed that cognitive impairment is very common in elderly heart failure patients and that these patients require specialist care...
August 2004: European Journal of Heart Failure
https://www.readbyqxmd.com/read/15202610/the-association-between-congestive-heart-failure-and-chronic-renal-disease
#7
REVIEW
Donald Silverberg, Dov Wexler, Miriam Blum, Doron Schwartz, Adrian Iaina
PURPOSE OF REVIEW: Recent findings on the relationship between congestive heart failure and renal failure are summarized in this review. RECENT FINDINGS: Congestive heart failure is found in about one-quarter of cases of chronic kidney disease. The most common cause of congestive heart failure is ischemic heart disease. The prevalence of congestive heart failure increases greatly as the patient's renal function deteriorates, and, at end-stage renal disease, can reach 65-70%...
March 2004: Current Opinion in Nephrology and Hypertension
https://www.readbyqxmd.com/read/11048403/-cardiology-at-the-end-of-the-20th-century
#8
P Jerie
In autumn 1999 results of two well-controlled studies were published that are consistent with a frequent association between Helicobacter pylori seropositivity and coronary heart disease (CHD). Concerning the therapy of CHD, attention is mainly focused on new thrombolytic agents, bypass grafting (CABG) and balloon angioplasty (PTCA). In patients with intractable angina where aggressive medical therapy was exhausted and who were no longer candidates for CABG or PTCA, transmural laser revascularisation (TMLR), enhanced external counterpulsation (EECP) and spinal cord stimulation can be considered...
July 19, 2000: Casopís Lékar̆ů C̆eských
https://www.readbyqxmd.com/read/9675959/-complex-ventricular-arrhythmias-and-carvedilol-efficacy-in-hemodialyzed-uremic-patients
#9
REVIEW
G Cice, E Tagliamonte, L Ferrara, A Di Benedetto, A Iacono
Carvedilol has been shown to be effective in systemic hypertension and coronary artery disease in patients with end-stage renal disease, on maintenance hemodialysis. The aim of our study was to assess the effects of carvedilol on ventricular arrhythmias in these patients. Ninety-eight uremic patients maintained on hemodialysis, with complex ventricular arrhythmias (class III, IV and V of Lown's classification), not only during dialysis, were included in the study. They were divided into two groups, with mild-to-moderate hypertension or coronary artery disease...
June 1998: Cardiologia: Bollettino Della Società Italiana di Cardiologia
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"